The 2nd Edition of the International Cancer & Immuno-Oncology Conference (CIOC 2026) was successfully held in a hybrid format from March 19–21, 2026, featuring in-person sessions in Singapore alongside global virtual participation. Centered on the theme “Transforming Cancer Care: Innovations, Integrations, and Impact,” the conference brought together a diverse community of researchers, scientists, clinicians, and industry professionals to exchange knowledge and explore the latest advancements in cancer research. The event showcased a well-curated scientific program covering both fundamental and translational research, while fostering meaningful networking, collaboration, and the development of lasting professional connections.
Latest highlights & testimonials
Title : Nasopharyngeal carcinoma: A “different” head and neck tumour
Pietro Salvatori, Formerly, Humanitas San Pio X Hospital, Italy
Title : Building bridges: Mechanisms that prevent chromatin bridge breakage in cytokinesis
George Zachos, University of Crete, Greece
Title : Personalized and Precision Medicine (PPM) through the view of biodesign-inspired translational research: An option for clinical oncologists, caregivers, and consumers to realize the potential of genomics-informed care to secure human biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Theranostic nanoparticles combined particle therapy
Sandrine Lacombe, University of Paris-Saclay, France
Title : The art of patient conversation in oncology
Stephan Bodis, University Zurich, Switzerland
Title : Updates on controversies surrounding the staging and management of newly diagnosed localized prostate cancer using Prostate-Specific Membrane Antigen (PSMA) positron emission tomography
Patricia Tai, University of Saskatchewan, Canada